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SHORT COMMUNICATION

Imaging Patterns of Encephalopathy in Patients with
COVID-19
Kumail Khandwala, Fatima Mubarak and Muhammad Nadeem Ahmad
Department of Radiology, The Aga Khan University Hospital, Karachi, Pakistan

ABSTRACT
The aim of this retrospective observational study was to describe the neuroimaging manifestations of patients with COVID-19.
This study was conducted at Aga Khan University Hospital, Karachi, Pakistan from March to July 2020. COVID-19 patients with
neurological symptoms and positive neuroimaging were included after conﬁrmation of COVID-19 by polymerase chain reaction
test (PCR). In the 12 included patients, seizures and altered mentation were predominant neurological manifestations. Three
cases had acute watershed infarcts (25%), two cases had posterior cerebral artery territorial infarcts (16.7%), two cases had
periventricular corona radiata infarcts (16.7%), three cases had hypoxic ischemic encephalopathy (25%), two cases had posterior reversible encephalopathy syndrome (16.7%), and there was one case each of cerebral venous sinus thrombosis, pontine
infarct, and bithalamic lesions (8.3%). This study highlights the diagnostic approaches in COVID-19-associated encephalopathy
and the variable imaging features that clinicians and neuroradiologists should be aware of, as the pandemic progresses.
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Coronavirus disease (COVID-19) originated in December 2019 in
Wuhan, China, probably from an animal source, and has since
then had a rapid rate of transmission to the rest of the world, and
being declared a global pandemic by the World Health Organisation. The typical symptoms of COVID-19 are respiratory-related.
The elderly, especially those with comorbid conditions, are more
likely to develop critical illness resulting in high mortality rates in
this age group.
COVID-19 has characteristic laboratory ﬁndings and lung radiographic and computed tomography (CT) abnormalities.
However, neuroimaging features in COVID-19 patients have not
been widely documented as yet. According to the available literature, patients with COVID-19 infection can present with acute
encephalopathy with changes in their level of consciousness,
acute stroke, as a result of thromboembolic phenomena and/or
1
seizures.
In this study, the authors report cases of COVID-19 patients, who
presented with neurological manifestations, and describe their
relevant neuroimaging features. To date, these are the ﬁrst
reported cases of COVID-19 from the subcontinent with positive
ﬁndings on neuroimaging.
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This was a retrospective-descriptive study commenced after
approval was obtained from the Ethical Review Committee. Patients with COVID-19, who presented with neurological symptoms to the Aga Khan University Hospital, Karachi, Pakistan
from March 2020 to July 2020, were included after they had
neuroimaging done from the Radiology Department of this
hospital. Severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) infection was conﬁrmed by quantitative RT-PCR
by nasopharyngeal or oropharyngeal swab. Patient demographic data, comorbid conditions, neurological symptoms and
relevant investigations (laboratory and neurophysiology) were
retrieved from the electronic records of the patients. Patients
who had negative imaging ﬁndings were excluded.
Data entry and analyses were carried out on Microsoft Excel.
Quantitative demographic data were reported as mean ± standard deviation. The qualitative data was expressed as
frequency (percentage).
A total of 12 patients with SARS-CoV-2 infection met the inclusion criteria and had neurological involvement with positive
imaging ﬁndings. There were two pediatric patients. The mean
age was 48.1 ± 28.3 years (range, 0.5-81). A summary of the
demographic data, clinical and neuroimaging features are
provided in Table I. Neurological symptoms included seizures
and altered mentation (n = 5), drowsiness (n = 4), encephalopathy (n = 3), acute loss of consciousness (n = 2), motor weakness (n = 3), and headache and anosmia (n = 1). Neurological
symptoms were part of the initial presentation in four patients
(33.3%).
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Table I: Summary of patient demographic details, comorbidities, clinical presentation and neuroimaging ﬁndings.

Patient demographics &
comorbidities

Neurological clinical presentation

Neuroimaging ﬁndings

6 month old male, VSD and PDA

GTC, moderate encephalopathy

Bilateral acute internal watershed territory infarcts with PRES
and microhemorrhages

3 year old female, NKCM

GTC, altered mentation, quadriparesis

Bithalamic non-diﬀusion restricted lesions

29 year old male, NKCM

Anosmia, GTC, headache, mild
encephalopathy

Cerebral venous sinus thrombosis with hemorrhagic venous
infarct

35 year old male, NKCM

Acute loss of consciousness

Global hypoxic ischemic encephalopathy

38 year old female, SLE and
hypothyroidism

GTC and altered mentation, severe
encephalopathy

PRES, holohemispheric encephalopathy without diﬀusion
restriction

41 year old male, NKCM

Drowsiness, altered mentation

Global hypoxic ischemic encephalopathy and multifocal
microhemorrhages

56 year old male, NKCM

GTC

Global hypoxic ischemic encephalopathy/postictal

68 year old female, DM, HTN and
asthma

Drowsiness and altered mentation

Right posterior cerebral artery acute infarct with hemorrhagic
conversion

72 year old female, CLD

Acute loss of consciousness

Small acute infarct in left corona radiata

75-year old male, DM, CHD

Drowsiness and new onset left sided
peripheral motor weakness

Subacute infarction in the right posterior cerebral artery
territory with hemorrhagic conversion

79-year-old female, DM, HTN

Drowsiness and altered mentation

Bilateral internal watershed infarcts, pontine infarct

81 year old male, chronic atrial
ﬁbrillation and asthma

Drowsiness and new onset left sided
hemiparesis

Left internal watershed infarcts, left occipital lobe,
periventricular corona radiata

VSD: Ventricular septal defect, PDA: Patent ductus arteriosus, GTC: Generalised tonic seizures, PRES: Posterior reversible encephalopathy syndrome,
NKCM: No known comorbidities, SLE: Systemic lupus erythematosus, DM: Diabetes mellitus, HTN: Hypertension, CHD: Congestive heart disease
Figure 1: (A&B) Coronal FLAIR images of a 38-year female, showing
hyperintense signals in the parieto-occipital white matter and bilateral centrum semiovale, suggestive of PRES and a holohemispheric
pattern of encephalopathy (arrows). These signals did not show diﬀusion restriction. (C) Axial DWI B-value 1000 image showing diﬀusion
restriction in the basal ganglia and posterior parieto-occipital
cortices of a 41 year old male suggestive of hypoxic ischemic injury.
(D) Multifocal susceptibility dropout in the same patient, indicative
of microhemorrhages.

Systemic manifestations included fever (n = 7), dyspnea
(n = 4), cough (n = 3), and hypernatremic dehydration (n =
1). Five patients (41.7%) had no known comorbidities. Electroencephalography showed mild, moderate and severe
encephalopathy in the three out of four patients tested. One
patient had continuous epileptiform discharges with
myoclonic jerks and was subsequently diagnosed with
postictal encephalopathy on imaging. Eight patients (66.7%)
showed raised D-dimer levels (above the normal reference
values).
Neuroimaging revealed three cases with acute diﬀusion
restricted internal border zone watershed infarcts (25%),
and two cases with acute and subacute right sided posterior
cerebral artery territorial infarcts with areas of hemorrhagic
conversion (16.7%). There were three cases of hypoxic
ischemic encephalopathy (25%), two cases of posterior
reversible encephalopathy syndrome (16.7%), two cases of
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multiple microhemorrhages (16.7%) two cases of periventricular corona radiata infarcts (16.7%), and one case each of
cerebral venous sinus thrombosis, pontine infarct, and nondiﬀusion restricted bi-thalamic lesions (8.3%, Figures 1 and 2).

It was, however, found that the patterns of encephalopathy
encountered predominantly involving the posterior circulation and watershed areas, suggesting that these areas are
prone to hypoperfusion and are therefore more vulnerable in
this disease. Both cases of acute territorial infarction in this
study involved the posterior cerebral artery territory, with
areas of hemorrhagic conversions, also indicating that these
are the more likely arterial territories to be aﬀected. A plausible explanation may be deﬁcient adrenergic sympathetic
innervations in the vertebrobasilar system than in the
carotid system. A proposition for increased incidence of
stroke and thromboembolic phenomena in COVID-19 may
also be cytokine storm syndrome, related to the prothrom4
botic eﬀect of the inﬂammatory response.
Two patients had multifocal microhemorrhages; one patient
with extensive cerebral venous sinus thrombosis involving
the superior sagittal sinus, right transverse and sigmoid
sinuses had a large hemorrhagic venous infarct in the right
frontal lobe. There was one patient with spontaneous intracerebral hemorrhage and cerebral venous sinus thrombosis
each in the study from Wuhan, China, as well.1 It has been
hypothesised that brain angiotensin converting enzyme II
could be involved in COVID-19 infection; and its dysfunction,
leading to disruption of cerebral autoregulation and hemor5
rhage, due to arterial wall rupture.

Figure 2: (A) Axial T2 weighted sequence showing bilateral parieto-occipital hyperintensities, suggestive of PRES, with splenial signal
abnormality in a 6-month boy with COVID-19. (B) Axial DWI in the
same patient showing bilateral diﬀusion restricted internal watershed territory infarcts. (C&D) Axial T2 and coronal FLAIR in a 3-year
girl with bithalamic signal abnormalities extending to the cerebral
peduncles. These were not diﬀusion restricted or showing any hemorrhage.

SARS-COV-2 may enter the central nervous system (CNS)
through the hematogenous or retrograde neuronal route, as
seen with other respiratory viruses. The latter is advocated
by the fact that some patients had experienced anosmia,
including one patient in this series. The data regarding
COVID-19 neurological manifestations and neuroimaging
features is scarce.1 This study demonstrated that the neuroimaging features of COVID-19 patients were variable. Acute
ischemic infarcts and diﬀerent patterns of encephalopathy
were predominant in these patients. The encephalopathy
spectrum in this series included posterior reversible
encephalopathy syndrome (PRES), global hypoxic-ischemic
encephalopathy, and cortical and deep grey matter pattern
of T2 FLAIR hyperintense signal with associated restriction
diﬀusion that may be caused by hypoxic/ischemic or postictal eﬀects. This has also been similarly reported by
Mahammedi et al.2
Bilateral frontotemporal hypoperfusion has been noted in
patients who underwent perfusion imaging in a prior study.3
S44

This study also included two pediatric cases, one of whom
had watershed ischemic insults with PRES and microhemorrhages, and the other had bithalamic non-diﬀusion restricted
lesions without any hemorrhage or enhancement. Interestingly, the ﬁrst reported case of COVID-19–associated acute
necrotising hemorrhagic encephalopathy showed involvement of bilateral thalami. These types of bithalamic abnormalities have also been noted in other viral encephalitides.
Signal abnormality was seen in the splenium of corpus
callosum of the pediatric patient with watershed infarcts and
PRES. This is similar to a recent study in which acute splenial
lesions were noted in all four pediatric cases with COVID-19
related encephalopathies.6 The changes are thought to be
attributable to focal intramyelinic edema secondary to
inﬂammation, but may also be seen in other types of viral
illnesses.
Regarding meningoencephalitis, none of our cases showed
abnormal parenchymal or leptomeningeal enhancement. A
study done in France showed a high incidence of leptomeningeal enhancement, predominantly in occipital lobe in
8 out of their 13 patients.3 Some authors, however, propose
that CSF titers of the virus may be extremely low and dissemination is usually transient.
The key limitations of this study are the small sample size
and single-centre experience. Additionally, it could not be
determined whether these ﬁndings were coincidental or
speciﬁc to COVID-19 infection. Further studies are warranted
to validate the pathogenesis and mechanism of neurological
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involvement in this multisystemic viral syndrome. However,
neurologists and neuroradiologists should be aware of the
wide spectrum of neuroimaging patterns associated with
COVID-19, as this pandemic progresses. Overall, this article
indicates that the CNS may be variably involved in COVID-19
and highlights the diagnostic approaches to SARS-CoV-2
associated encephalopathy.
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